← Back to PVLA

Palvella Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 04/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 04/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
$0$0$0
−$22−$16−$11−$9.5−$8.2−$6.8−$4.2−$2.5
−$1.52−$1.20−$1.03−$0.86−$0.74−$3.94−$2.47−$1.54
14131111111.81.8

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.